RI
ABBV icon

Rudd International’s AbbVie ABBV Stock Holding History

Rudd International’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-51,617
Closed -$4.16M – 77
2019
Q1 		$4.16M Buy
51,617
+283
+0.6% +$23.2K 2.6% 14
2018
Q4 		$4.73M Buy
+51,334
New +$4.51M 3.46% 4

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Rudd International's ABBV Position: Q2 2019 in Review

Rudd International sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 51,617 shares — an estimated $4.16M sold.

Rudd International first reported a position in ABBV in Q4 2018 and held it in 2 quarters. The position peaked at $4.73M in Q4 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Rudd International reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
  • Rudd International sold 51,617 AbbVie shares in Q2 2019, an estimated $4.16M.
  • Rudd International first reported a position in AbbVie in Q4 2018 and held it in 2 quarters.
  • Rudd International's AbbVie position peaked at $4.73M in Q4 2018.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Rudd International's 13F filing for Q2 2019, filed 2 Aug 2019.